You are here
CRT has an impressive range of over 200 oncology-focused projects under development and potentially available for licensing or collaboration. All are involved in the fight against cancer and include novel chemotherapeutic and biological agents, diagnostic methodologies and enabling technologies. The projects range from new targets to therapies in pre-clinical development to those in Phase I/II clinical studies.
View our opportunities using the navigation below, or view a summary here.